(Q35561693)

8 August 2017

1 reference

title

Practical approach to non-alcoholic fatty liver disease in patients with diabetes (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

8 August 2017

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

F W D Tai

1

1 reference

PubMed ID

25683343

8 August 2017

W-K Syn

series ordinal

2

1 reference

PubMed ID

25683343

8 August 2017

W Alazawi

series ordinal

3

1 reference

8 August 2017

12 February 2015

1 reference

8 August 2017

1 reference

8 August 2017

32

1 reference

8 August 2017

9

1 reference

8 August 2017

1121-1133

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

8 August 2017

1 reference

Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists

21 January 2018

1 reference

The epidemiology, pathogenesis and histopathology of fatty liver disease

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

21 January 2018

1 reference

Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

21 January 2018

1 reference

Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes

21 January 2018

1 reference

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

21 January 2018

1 reference

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

21 January 2018

1 reference

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.

21 January 2018

1 reference

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

21 January 2018

1 reference

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population

21 January 2018

1 reference

Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population

21 January 2018

1 reference

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

21 January 2018

1 reference

Racial differences in nonalcoholic fatty liver disease in the U.S. population

21 January 2018

1 reference

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

21 January 2018

1 reference

Ethnicity and the diagnosis gap in liver disease: a population-based study

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

21 January 2018

1 reference

Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.

21 January 2018

1 reference

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

21 January 2018

1 reference

Coffee consumption and risk of type 2 diabetes: a systematic review

21 January 2018

1 reference

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

21 January 2018

1 reference

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

Nonalcoholic fatty liver disease in patients with type 2 diabetes

21 January 2018

1 reference

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

21 January 2018

1 reference

HCC and NASH: how strong is the clinical demonstration?

21 January 2018

1 reference

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

21 January 2018

1 reference

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

21 January 2018

1 reference

Noninvasive evaluation of NAFLD.

21 January 2018

1 reference

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments

21 January 2018

1 reference

A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.

21 January 2018

1 reference

Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.

21 January 2018

1 reference

Extrahepatic complications of nonalcoholic fatty liver disease

21 January 2018

1 reference

Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

21 January 2018

1 reference

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

21 January 2018

1 reference

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

21 January 2018

1 reference

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

APOC3 and PNPLA3 in non-alcoholic fatty liver disease: Need to clear the air

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12725

1 reference

8 August 2017

1 reference

PubMed ID

25683343